BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18025232)

  • 1. A complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA/1J mice.
    Song H; Qiao F; Atkinson C; Holers VM; Tomlinson S
    J Immunol; 2007 Dec; 179(11):7860-7. PubMed ID: 18025232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis.
    Banda NK; Kraus D; Vondracek A; Huynh LH; Bendele A; Holers VM; Arend WP
    Arthritis Rheum; 2002 Nov; 46(11):3065-75. PubMed ID: 12428251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice.
    Banda NK; Tomlinson S; Scheinman RI; Ho N; Ramirez JR; Mehta G; Wang G; Vu VP; Simberg D; Kulik L; Holers VM
    Front Immunol; 2020; 11():575154. PubMed ID: 33178202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of collagen-induced arthritis in mice transgenic for the complement inhibitor complement receptor 1-related gene/protein y.
    Banda NK; Kraus DM; Muggli M; Bendele A; Holers VM; Arend WP
    J Immunol; 2003 Aug; 171(4):2109-15. PubMed ID: 12902517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement receptor CR2/CR1 deficiency protects mice from collagen-induced arthritis and associates with reduced autoantibodies to type II collagen and citrullinated antigens.
    Kuhn KA; Cozine CL; Tomooka B; Robinson WH; Holers VM
    Mol Immunol; 2008 May; 45(10):2808-19. PubMed ID: 18374982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; HeinegÄrd D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models.
    Fridkis-Hareli M; Storek M; Or E; Altman R; Katti S; Sun F; Peng T; Hunter J; Johnson K; Wang Y; Lundberg AS; Mehta G; Banda NK; Michael Holers V
    Mol Immunol; 2019 Jan; 105():150-164. PubMed ID: 30513451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice.
    Atkinson C; Qiao F; Song H; Gilkeson GS; Tomlinson S
    J Immunol; 2008 Jan; 180(2):1231-8. PubMed ID: 18178863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.
    Atkinson C; Song H; Lu B; Qiao F; Burns TA; Holers VM; Tsokos GC; Tomlinson S
    J Clin Invest; 2005 Sep; 115(9):2444-53. PubMed ID: 16127466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice.
    Banda NK; Levitt B; Glogowska MJ; Thurman JM; Takahashi K; Stahl GL; Tomlinson S; Arend WP; Holers VM
    J Immunol; 2009 Nov; 183(9):5928-37. PubMed ID: 19828624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor.
    Quigg RJ; Kozono Y; Berthiaume D; Lim A; Salant DJ; Weinfeld A; Griffin P; Kremmer E; Holers VM
    J Immunol; 1998 May; 160(9):4553-60. PubMed ID: 9574562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement deficiency ameliorates collagen-induced arthritis in mice.
    Hietala MA; Jonsson IM; Tarkowski A; Kleinau S; Pekna M
    J Immunol; 2002 Jul; 169(1):454-9. PubMed ID: 12077276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice.
    Bao L; Haas M; Kraus DM; Hack BK; Rakstang JK; Holers VM; Quigg RJ
    J Am Soc Nephrol; 2003 Mar; 14(3):670-9. PubMed ID: 12595503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice.
    Guo Z; Chen J; Zeng Y; Wang Z; Yao M; Tomlinson S; Chen B; Yuan G; He S
    Front Immunol; 2021; 12():785287. PubMed ID: 35069557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma.
    Qiao F; Atkinson C; Song H; Pannu R; Singh I; Tomlinson S
    Am J Pathol; 2006 Sep; 169(3):1039-47. PubMed ID: 16936276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor.
    Qiu S; Liu N; Jia L; Yang G; Su W; Li J; Song L; Yang C; Wang J; Zhang C; Wang Z; Qiao F; Tomlinson S; Atkinson C; Sun Y; Huang L; Song H; Wang Y; Li Z
    Virol J; 2012 Nov; 9():285. PubMed ID: 23173749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
    Zhu P; Bailey SR; Lei B; Paulos CM; Atkinson C; Tomlinson S
    Transplantation; 2017 Apr; 101(4):e75-e85. PubMed ID: 28045880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis.
    Banda NK; Thurman JM; Kraus D; Wood A; Carroll MC; Arend WP; Holers VM
    J Immunol; 2006 Aug; 177(3):1904-12. PubMed ID: 16849503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement-dependent P-selectin expression and injury following ischemic stroke.
    Atkinson C; Zhu H; Qiao F; Varela JC; Yu J; Song H; Kindy MS; Tomlinson S
    J Immunol; 2006 Nov; 177(10):7266-74. PubMed ID: 17082645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein.
    Banda NK; Vondracek A; Kraus D; Dinarello CA; Kim SH; Bendele A; Senaldi G; Arend WP
    J Immunol; 2003 Feb; 170(4):2100-5. PubMed ID: 12574381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.